Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
Authors:
Open Access
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 149 (4) , 1358-1372
Abstract
No abstract availableKeywords
Funding Information
- European Coordinated Research on Long-term Challenges in Information and Communication Sciences & Technologies ERA-NET
- NIH
- Fondation Imagine
- ANR
This publication has 70 references indexed in Scilit:
- Netherton syndrome: skin inflammation and allergy by loss of protease inhibitionCell and tissue research, 2013
- Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin modelAllergy, 2012
- Regulation of human Th9 differentiation by type I interferons and IL‐21Immunology & Cell Biology, 2010
- Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessingJournal of Clinical Investigation, 2010
- Comèl-Netherton syndrome defined as primary immunodeficiencyJournal of Allergy and Clinical Immunology, 2009
- Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndromeJournal of Experimental Medicine, 2009
- Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationJournal of Experimental Medicine, 2007
- LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent InteractionMolecular Biology of the Cell, 2007
- Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton SyndromeJournal of Investigative Dermatology, 2006
- Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivityNature Genetics, 2004